NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Freenome

Freenome

Public
South San Francisco, CaliforniaBiotechhttps://www.freenome.com/

Freenome is now publicly traded

The data on this page reflects Freenome's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

PIPE

Dec 5, 2025

Est. Valuation at Exit

$965M

Total Funding Raised

$1.6B

Company Overview

Freenome is a biotechnology company that develops noninvasive blood-based screening tests for early cancer detection using a multiomics platform powered by machine learning.

Sector

Biotech

Verticals

HealthTech, Life Sciences, Oncology

AI Layer

Application

Keywords

liquid biopsycolorectal cancer screeningCRC screeningmultiomicsearly cancer detectioncancer diagnosticsblood-based testbiomarker discoverymedical AIprecision medicineclinical diagnosticsnon-invasive screeningAI-driven diagnosticsbiotech

Freenome Comparables

Compare Freenome with similar companies based on industry and business-model similarity.

Freenome comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Universal Diagnostics
87%
Guardant Health
83%
Delfi Diagnostics
81%

Freenome Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
PIPEDec 5, 2025
VC RoundFeb 15, 2024
Series D ExtensionJan 11, 2022
Series DDec 7, 2021
Series CAug 26, 2020
Series B
Jul 24, 2019

Key People

Founding team and executive leadership

Aaron Elliott

Chief Executive Officer

Executive Team

Freenome Investors

Notable investors and investment history

Freenome investors
InvestorRounds
EcoR1 CapitalSeries C
Andreessen HorowitzSeries B, Series C, Series A, Seed
S32VC Round, Series B, Series D, Series C, Series A
Soleus CapitalSeries D, Series C
Bain Capital Life SciencesVC Round, Series D, Series D Extension, PIPE, Series C
Janus Henderson GroupSeries D, Series C
RA Capital AdvisorsSeries D, VC Round

Freenome Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Freenome Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range402
Year Founded2014
Last FundingDec 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.